---
DrugClass: "[[Skeletal Muscle, Bone, and Joint Disorder Drugs]]"
SubClass: "[[Skeletal muscle relaxants]]"
DrugClassContra: "[[Skeletal muscle relaxants#Contraindications]]"
DrugClassAdverse: "[[Skeletal muscle relaxants#Adverse Reactions]]"
SecondaryDrugClass: 
SecondarySubClass: 
BrandName: Ozobax
Chapter: "29"
KindleLinkChap: "[Chapter 29](kindle://book?action=open&asin=B09FRF11YJ&location=15248)"
KindleLink: 
tags:
  - Drug
  - Pharmacology
Course: Pharmacology
ChemLink: https://pubchem.ncbi.nlm.nih.gov/#query=
---
```smiles
C1=CC(=CC=C1C(CC(=O)O)CN)Cl
```

### Brand name
`=this.BrandName`

### Generic name
`= this.file.name`

### Drug class 
`= this.DrugClass`
	`= this.DrugClass.KindleLinkChap`

### Dosage & Usage
Spasticity caused by multiple sclerosis, [[Spinal cord]] injuries ([[intrathecal]] administration for severe spasticity)
15â€“ 80 mg/ day orally in divided doses

### Contraindications
See `= this.DrugClassContra`

### Mechanisms of Action

### Side/Adverse Effects
See `= this.DrugClassAdverse`
Drowsiness, dizziness, nausea, weakness, hypotension

### Interactions

`= this.ChemLink+this.file.name`

